Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Finasteride shows promise for female hair loss, but more research needed.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride may help some women with hair loss, but better options exist.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

AR gene not major factor in female hair loss; different from male hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Nanog gene boosts stem cells, helps hair growth, and may treat hair loss.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Adults with persistent scalp issues unresponsive to typical treatments should be tested for the fungal infection tinea capitis to start the right antifungal medication.